191 related articles for article (PubMed ID: 27231797)
1. A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease.
Sabater-Hernández D; Sabater-Galindo M; Fernandez-Llimos F; Rotta I; Hossain LN; Durks D; Franco-Trigo L; Lopes LA; Correr CJ; Benrimoj SI
J Manag Care Spec Pharm; 2016 Jun; 22(6):699-713. PubMed ID: 27231797
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review.
Evans CD; Watson E; Eurich DT; Taylor JG; Yakiwchuk EM; Shevchuk YM; Remillard A; Blackburn D
Ann Pharmacother; 2011 May; 45(5):615-28. PubMed ID: 21558487
[TBL] [Abstract][Full Text] [Related]
9. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients.
Zolezzi M; Abdallah O; Kheir N; Abdelsalam AG
Res Social Adm Pharm; 2019 Mar; 15(3):252-259. PubMed ID: 29753643
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease.
Altowaijri A; Phillips CJ; Fitzsimmons D
J Manag Care Pharm; 2013 Jun; 19(5):408-16. PubMed ID: 23697478
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.
Steed L; Sohanpal R; Todd A; Madurasinghe VW; Rivas C; Edwards EA; Summerbell CD; Taylor SJ; Walton RT
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011207. PubMed ID: 31808563
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.
Al Raiisi F; Stewart D; Fernandez-Llimos F; Salgado TM; Mohamed MF; Cunningham S
Int J Clin Pharm; 2019 Jun; 41(3):630-666. PubMed ID: 30963447
[TBL] [Abstract][Full Text] [Related]
14. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis.
Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
Saudi Pharm J; 2020 May; 28(5):529-537. PubMed ID: 32435133
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?
Almansour HA; Aloudah NM; Alhawassi TM; Chaar B; Krass I; Saini B
J Pharm Policy Pract; 2021 May; 14(1):42. PubMed ID: 33958004
[TBL] [Abstract][Full Text] [Related]
16. Role and impact of pharmacists in Spain: a scoping review.
Saavedra-Mitjans M; Ferrand É; Garin N; Bussières JF
Int J Clin Pharm; 2018 Dec; 40(6):1430-1442. PubMed ID: 30367376
[TBL] [Abstract][Full Text] [Related]
17. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
18. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
19. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
20. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
Sato N; Fujita K; Kushida K; Chen TF
Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
